COVID 19 booster shots | Business Upturn

‘My booster dose’: The 69-year-old actor Shakti Kapoor takes Covid-19 shot

Simnan Vora — Sat, 15 Jan 2022 10:24:58 +0000

The veteran actor Shakti Kapoor gets a Covid-19 booster shot, after getting the original dose of vaccine.

On Saturday, the 69-year-old actor Shakti Kapoor posted an Instagram story of himself getting the booster dose. In the background, we can hear the song along with the lyrics ‘Love You Zindagi’. He later shared a video of himself jamming on ‘Chand Chhupa Badal Mein’ on guitar.

After actor Dharmendra, Shakti Kapoor is the latest celebrity to receive the Covid-19 booster dose.

The booster shot helps in improving and protecting people from their first two doses of the Covid-19 vaccine, 60 plus people are eligible for booster jab. The hustle proceeded as the whole world combats a peg in COVID-19 cases fueled by the Omicron variant of the coronavirus.

On the professional front, Shakti Kapoor has done more than 700 films his debut film was ‘Khel Khiladi Ka’ which was released in 1977 and then he was next seen in ‘Qurbani’ in 1980, in this film he had played a role of a villain this film was a super hit. After a year he was seen in ‘Rocky’ which was a debut film by Sunjay Dutt. In the 90s Shakti Kapoor was mostly seen playing roles as a villain, he has also worked in many comedy films and made people laugh through his acting. His most loved film was ‘Raja Babu which was released in 1994, for this film Shakti Kapoor has won the Best Comedian award in Filmfare.

Johnson & Johnson’s single-dose COVID-19 vaccine gets EUA in India

Aayushi Singh — Sat, 07 Aug 2021 08:46:14 +0000

On Saturday, Mansukh Mandaviya, Union Health Minister, had said that Johnson&Johnson’s single-dose COVID-19 vaccine had been given approval for emergency use in India. He said that now India has 5 EUA vaccines which would further boost the nation’s collective fight against COVID-19.

The Phase 3 Ensemble Clinical trial demonstrated Johnson& Johnson’s single-shot vaccines to be 85 per cent effective in the prevention of severe diseases across every region studied and the vaccine also showed protection against the hospitalisation and deaths related to COVID-19, which began 28 days post-vaccination, all this was the base of the EUA submission.

The statement added that it was an important milestone that has paved the way to bring the company’s single-dose COVID-19 vaccine to the people of India and for the rest of the world with a collaboration with Biological E Limited.

The statement further said that they were looking forward to concluding their discussions with the government of India in order to accelerate the availability of their COVID-19 vaccine to end the pandemic.

India expands its vaccine basket!

Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India.

Now India has 5 EUA vaccines.

This will further boost our nation's collective fight against #COVID19

— Dr Mansukh Mandaviya (@mansukhmandviya) August 7, 2021

AIIMS chief explains the need of COVID vaccine booster shots

Bhaswati Sengupta — Sat, 24 Jul 2021 09:27:07 +0000

The Chief of All India Institute of Medical Science (AIIMS), Dr. Randeep Guleria stated, as mutations of the coronavirus emerge, the beneficiaries who have been vaccinated may still need a booster with a second-generation COVID 19 shot.

News agency ANI quoted Dr. Guleria who explains,” It seems that we probably need the booster dose of vaccine as with the passage of time the immunity tends to falls. There is warning immunity. We would like to have a booster dose that will cover for various emerging variants.”

Further, he added, “We will have second-generation vaccines which would be better in terms of the immunity they give, covering of the new variants and a having a better overall efficacy. Trails of booster vaccines shots are already going on.”

He emphasized an appropriate timeline of when the booster dose should be administered. He stated that an individual will probably require a booster dose till the end of this year. However, he notified that it will be applicable once the population is vaccinated.

International discourse

Guleria’s words follow after the European Medicines Agency stated that it is too earlier to determine the need for more than the two shots of the COVID 19 vaccines. Furthermore, it voiced that it was confident for now that the established regimen was sufficient.

Reportedly, experts across the world are examining closely to determine if and when people might need another shot.

Many experts suggest that priority for the time being should be the first round of vaccinations, nothing that worrisome coronavirus mutants would not be popping up so fast if more of the world had gotten the initial rounds of shots.

Earlier, US Health officials proposed that people might need a booster one day. However, the World Health Organization asserted that there is not enough evidence to affirm that third doses are needed. It noted that the scarce shots should be shared with the poor countries instead of being used by rich countries as boosters.

Covaxin booster dose trials

As earlier reported, results of trials of the third booster doses of Bharat Biotech’s COVID 19 vaccines Covaxin are likely to come by the end of November of the ongoing year.

The booster dose of the indigenously manufactured vaccine was first launched in the month of May. Following, its trials commenced at the AIIMS in Delhi and Patna. Nearly 12 centers across the country are conducting trials for the Covaxin booster shots.

Bharat Biotech received its permission to conduct the clinical trials from the Drug Controller General of India in the month of April. The outcome of the first trial is expected in the month of august while the second trial results are likely to arrive in November 2021.

The trials examined the immunogenicity, safety, reactogenicity, and tolerability of the Covaxin booster dose.